We are live on ! Find out more
MAM

Meeder Asset Management Portfolio holdings

AUM $1.96B
1-Year Est. Return 48.96%
This Fund
S&P 500
This Quarter Est. Return
+3.37%
1 Year Est. Return
+48.96%
3 Year Est. Return
+156.47%
5 Year Est. Return
+196.14%
10 Year Est. Return
+689.54%
AUM
$1.05B
AUM Growth
-$68.1M
Cap. Flow
-$92.6M
Cap. Flow %
-8.82%
Top 10 Hldgs %
22.12%
Holding
2,122
New
405
Increased
518
Reduced
436
Closed
484

Sector Composition

Rank Sector Weight
1 Technology 13.16%
2 Financials 12.43%
3 Healthcare 9.96%
4 Industrials 9.86%
5 Consumer Discretionary 8.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RAS
1301
DELISTED
RAIT Financial Trust
RAS
$4K ﹤0.01%
+1,611
New +$4.14K
HIBB
1302
DELISTED
Hibbett, Inc. Common Stock
HIBB
$4K ﹤0.01%
+202
New +$4.97K
BHVN
1303
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$4K ﹤0.01%
+141
New +$3.25K
AGEN
1304
Agenus
AGEN
$290M
$3K ﹤0.01%
37
-37
-50% -$2.6K
AGIO icon
1305
Agios Pharmaceuticals
AGIO
$1.93B
$3K ﹤0.01%
63
-28
-31% -$1.43K
AGM icon
1306
Federal Agricultural Mortgage
AGM
$2.56B
$3K ﹤0.01%
+49
New +$2.96K
ALTO icon
1307
Alto Ingredients
ALTO
$340M
$3K ﹤0.01%
+490
New +$3.18K
ATRA icon
1308
Atara Biotherapeutics
ATRA
$76.1M
$3K ﹤0.01%
9
-11
-55% -$4.24K
AXSM icon
1309
Axsome Therapeutics
AXSM
$10.9B
$3K ﹤0.01%
525
BANC icon
1310
Banc of California
BANC
$2.97B
$3K ﹤0.01%
155
+85
+121% +$1.79K
BLUE
1311
DELISTED
bluebird bio
BLUE
$3K ﹤0.01%
+2
New +$2.41K
CCRN
1312
DELISTED
Cross Country Healthcare
CCRN
$3K ﹤0.01%
237
-456
-66% -$5.88K
CDTX
1313
DELISTED
Cidara Therapeutics
CDTX
$3K ﹤0.01%
17
-14
-45% -$1.94K
CHMG icon
1314
Chemung Financial Corp
CHMG
$392M
$3K ﹤0.01%
+84
New +$3.27K
CNTY icon
1315
Century Casinos
CNTY
$34M
$3K ﹤0.01%
446
+273
+158% +$2.14K
DRRX
1316
DELISTED
DURECT Corp
DRRX
$3K ﹤0.01%
162
-656
-80% -$7.47K
ESSA
1317
DELISTED
ESSA Bancorp
ESSA
$3K ﹤0.01%
179
FMNB icon
1318
Farmers National Banc Corp
FMNB
$929M
$3K ﹤0.01%
223
+122
+121% +$1.72K
FOSL icon
1319
Fossil Group
FOSL
$318M
$3K ﹤0.01%
313
-157
-33% -$2.12K
GNE icon
1320
Genie Energy
GNE
$384M
$3K ﹤0.01%
351
-89
-20% -$680
GPRE icon
1321
Green Plains
GPRE
$1.03B
$3K ﹤0.01%
+148
New +$3.37K
IBRX icon
1322
ImmunityBio
IBRX
$8.1B
$3K ﹤0.01%
377
-1,328
-78% -$5.74K
IDT icon
1323
IDT Corp
IDT
$1.62B
$3K ﹤0.01%
235
+137
+140% +$1.78K
IMUX icon
1324
Immunic
IMUX
$195M
$3K ﹤0.01%
2
-1
-33% -$1.33K
OPLN
1325
Openlane
OPLN
$4.54B
$3K ﹤0.01%
161
-21,493
-99% -$350K

Similar funds

Meeder Asset Management's Q2 2017 Portfolio in Review

As of Q2 2017, Meeder Asset Management held 2,122 positions worth $1.05B, down 6.1% from $1.12B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Meeder Asset Management withdrew a net $92.6M in Q2 2017, closing 484 positions and reducing 436 holdings. Its most notable exit was iShares 20+ Year Treasury Bond ETF, an estimated $13M position sold in full.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 15% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Meeder Asset Management opened a new position in Humana worth $5.43M.

  • Meeder Asset Management's largest Q2 2017 buy was Humana: 22,582 shares worth $5.43M.
  • Meeder Asset Management added most to State Street SPDR Bloomberg High Yield Bond ETF in Q2 2017, an estimated $23.9M increase.
  • Meeder Asset Management's biggest Q2 2017 reduction was iShares MSCI EAFE ETF, cutting an estimated $41.8M.
  • Meeder Asset Management fully exited iShares 20+ Year Treasury Bond ETF in Q2 2017, selling an estimated $13M.
  • Meeder Asset Management's ten largest holdings make up 22% of its $1.05B portfolio in Q2 2017.
  • Meeder Asset Management opened 405 new positions and closed 484 in Q2 2017.
  • Meeder Asset Management's portfolio value fell 6.1% quarter-over-quarter to $1.05B.

Based on Meeder Asset Management's 13F filing for Q2 2017, filed 13 Jul 2017.